<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47006">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02039427</url>
  </required_header>
  <id_info>
    <org_study_id>YUH-3368-sore throat</org_study_id>
    <nct_id>NCT02039427</nct_id>
  </id_info>
  <brief_title>The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery</brief_title>
  <official_title>The Effect of Prophylactic Ketorolac on Sore Throat After Thyroid Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <authority>Korea: Ministry of Food and Drug Safety</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sore throat is one of most frequent complaints related to general anesthesia with tracheal
      intubation. Although sore throat is regarded as a minor and short-lasting discomfort after
      surgery, its incidence and intensity in high risk patients such as female gender, head and
      neck surgery and difficult laryngoscopy or intubation may attribute to prolong postoperative
      recovery and give patient dissatisfaction.

      Even though the pathophysiology of post-intubation airway symptoms is not completely
      clarified yet, the mucosal damage related inflammation at the cuff of endotracheal tube has
      been thought to be an essential trigger. Thus anti-inflammatory medication has been commonly
      used strategy to prevent postoperative airway discomfort after intubation. The preoperative
      administration of dexamethasone has been reported to reduce the incidence and severity of
      postoperative sore throat, but it is accompanied with the adverse effects such as
      hyperglycemia, delayed wound healing and increased infection in surgical patients.
      Ketorolac, non-steroidal anti-inflammatory drug (NSAID), is an analgesic that commonly used
      for postoperative pain control and has anti-inflammatory effect.

      Therefore, the investigator designed to evaluate the effect of ketorolac on sore throat in
      comparison to dexamethasone after thyroidectomy in female adult patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ketorolac, NSAID, has not been evaluated as a pharmacologic strategy to reduce postoperative
      sore throat yet. The investigator will explore how the analgesic and anti-inflammatory
      effects of ketorolac influence airway symptoms following general anesthesia with tracheal
      intubation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>incidence and severity of sore throat</measure>
    <time_frame>up to 24 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>&lt;Sore throat scale&gt; 0 none
mild (less severe than with a cold)
moderate (similar with a cold)
severe (more severe than with a cold)
Incidence of sore throat : if patient rates sore throat scale more than 1, investigator will record as positive symptom.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence and severity of hoarseness</measure>
    <time_frame>1. 1h after surgery, 2. 6h after surgery, 3. 24h after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hoarseness scale 0-3 0 none
mild (noted by the patient only)
severe (noticed by the time of the interview by the observer)
aphonia (silence of voice)
incidence of hoarseness: If patient exhibit hoarseness scale more than 1, investigator will record as positive sign</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia Intubation Complication</condition>
  <condition>Tracheal Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline(Placebo) 2 ml  5 min before induction Normal saline 2 ml  10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preketorolac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ketorolac 30 mg  5 min before induction Normal saline 2 ml  10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postketorolac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal saline 2 ml  5 min before induction Ketorolac 30 mg 10 min before end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 10 mg (total volume 2 ml) 5 min before induction Normal saline 2 ml  10 min before end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>ketorolac 30 mg mixed with normal saline 1 ml : total volume of 2 ml</description>
    <arm_group_label>Preketorolac</arm_group_label>
    <arm_group_label>Postketorolac</arm_group_label>
    <other_name>Kerola</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>dexamethasone acetate10 mg : total volume of 2 ml</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline 2 ml</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. American society of Anesthesiologists(ASA) physical status 1 and 2

          2. 20-60 years old female

          3. elective scheduled thyroidectomy

        Exclusion Criteria:

        surgery longer than 3 hours Previous history of or expected difficult tracheal intubation
        Laryngoscope grade (by Cormack and Lehane) of 3 or 4 2 more trial for intubation BMI &gt; 30
        Hypersensitivity to ketorolac history of asthma respiratory tract infection during the
        past 6 weeks Renal dysfunction (creatinine &gt; 1.5 mg/dl or oligouria) Hepatic dysfunction
        (ALT :&gt; 50% more than normal value) Use of corticosteroid, NSAIDS, angiotensin converting
        enzyme in 10 days Medication for gastritis, gastric ulcer Upper gastrointestinal  bleeding
        history Diabetes mellitus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Mee Jung, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung Mee Jung, M.D.</last_name>
    <phone>+82-53-620-3368</phone>
    <email>applejsm@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yeungnam University Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>705-717</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Mee Jung, M.D.</last_name>
      <phone>+82-53-620--3368</phone>
    </contact>
    <investigator>
      <last_name>Sung Mee Jung, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/15892411</url>
    <description>Complaints of sore throat after tracheal intubation: a prospective evaluation</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&amp;from_uid=15892411</url>
    <description>Gender differences in risk factors for airway symptoms following tracheal intubation</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/24357270</url>
    <description>Dexamethasone for preventing postoperative sore throat: a meta-analysis of randomized controlled trials</description>
  </link>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 17, 2014</lastchanged_date>
  <firstreceived_date>January 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Sung Mee Jung</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Sore throat</keyword>
  <keyword>Hoarseness</keyword>
  <keyword>Intubation</keyword>
  <keyword>Thyroidectomy</keyword>
  <keyword>Ketorolac</keyword>
  <keyword>Dexamethasone</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Tracheal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
